A Trial of SHR0302Base in Patients With Vitiligo

NCT06790862 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitiligo

Interventions

DRUG: SHR0302Base gel
DRUG: SHR0302Base gel placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.